CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma

NCT05948033 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: CD70-targeting CAR-T cells

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]